AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...
Category - Pharmaceuticals
Johnson & Johnson Reports Positive Phase 3 Results for...
Johnson & Johnson has released new Phase 3 clinical trial data showing that icotrokinra, a...
Sanofi’s Brivekimig Shows Positive Phase 2a Results in...
Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...
Pfizer and BioNTech Report Strong Immune Response from LP.8.1...
Pfizer and BioNTech have announced topline Phase 3 clinical trial data showing a robust immune...
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular...
Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Sanofi Gene Therapy Gains FDA Fast Track Designation for Wet Age...
Sanofi has announced that the US Food and Drug Administration (FDA) has granted Fast Track...
Libtayo Plus Chemotherapy Delivers Five-Year Survival Benefit in...
Regeneron Pharmaceuticals, Inc. has announced five-year follow-up results from its Phase 3 EMPOWER...
Glycomine Begins Global Phase 2b Clinical Trial of GLM101 for...
Glycomine, Inc., a clinical-stage biotechnology company, has announced the initiation of dosing in...
Case Study: PostNord TPL ensures GDP compliance with Vaisala’s...
PostNord TPL, part of the PostNord Group, operates one of the largest third-party logistics...
AbbVie shares Phase 2 EPCORE® NHL-6 data: outpatient first-full...
AbbVie has reported updated results from the Phase 2 EPCORE® NHL-6 study (NCT05451810) assessing...